VGLS Stock UPDATES VG Life Sciences Inc. (VGLS) 0.1048 09/09/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
VG Life Sciences Inc. (VGLS) 0.1048 $VGLS

VG Life Sciences Inc. Progress Update Phase I Cancer Study
GlobeNewswire - Thu Sep 04, 7:27AM CDT
VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces today an update to its physician-initiated IND phase I study to test safety and tolerability of its patented technology in patients with advanced stage solid tumors.

VG Life Sciences, Inc. - Product Pipeline Review - 2014
M2 - Thu Jul 24, 6:06AM CDT
Summary

VG Life Sciences, Inc. Announces Filing of Form 10 with the SEC.
GlobeNewswire - Mon Jun 23, 3:48PM CDT
VG Life Sciences, Inc. (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from autoimmune and infectious diseases.

Sepsis - Pipeline Review, H1 2014
M2 - Thu Jun 12, 3:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rc2rw6/sepsis_pipeline) has announced the addition of the "Sepsis - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Sepsis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sepsis and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope - The report provides a snapshot of the global therapeutic landscape of Sepsis - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Sepsis and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Sepsis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Companies Mentioned: - Baxter International - Daiichi Sankyo Company - Novo Nordisk - Takeda Pharmaceutical Company - Chiesi Farmaceutici - Chong Kun Dang - Eisai - Huons - MetrioPharm - Opsona Therapeutics - Asahi Kasei - MSM Protein Technologies - VG Life Sciences - OncoImmune - Serum Institute of India - Endacea - ISU ABXIS - KAEL-GemVax - biosyn Arzneimittel - Cognosci - Navigen Pharmaceuticals - Lead Discovery Center - Immune Response BioPharma - Novadiscovery - XImmune - Adrenomed - ImmunNovative Developments - Diomune For more information visit http://www.researchandmarkets.com/research/rc...s_pipeline

VG Life Sciences, Inc.'s Reports on Clinical Outcomes in Phase I Cancer Study
GlobeNewswire - Fri Mar 14, 5:07AM CDT
VG Life Sciences, (OTC Pink:VGLS) a biotechnology company, announces today an update to its Physician-IND Phase I Study to test tolerability and toxicity of its patented technology in patients with advanced stage solid tumors.

VG Life Sciences, Inc. Increases Authorized Shares
GlobeNewswire - Thu Jan 02, 11:15PM CST
VG Life Sciences, Inc., (OTC Pink: VGLS) a biotechnology company. Pursuant to a vote of the holders having a majority of the votes of the Company on December 31, 2013, the number of authorized shares of Common Stock of the Company has been increased to 150,000,000.

VG Energy Chief Scientist Awarded $200,000 AgriLife Grant to Study Lipid Secretion
PR Newswire - Thu Aug 08, 6:50PM CDT
VG Energy, an agricultural biotech company and wholly owned subsidiary of publicly traded VG Life Sciences Inc. (VGLS), announces today a $200,000 competitive grant from the Texas A&M AgriLife Research BioEnergy Initiatives Program for testing oil secretion technology.

VG Life Sciences, Inc. Reports on Scientific Advancements: Completion of Third Cohort of Phase I Clinical Trial; Grant from the American Heart Association; UniQuest Reports on LipidMax
PR Newswire - Thu Jul 25, 5:00AM CDT
SANTA BARBARA, Calif., July 25, 2013 /PRNewswire/--- VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces today several advancements as it relates to its scientific advancements

VG Life Sciences, Inc. Announces Management Changes
PR Newswire - Thu Jul 18, 7:30AM CDT
VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces alterations in its corporate management and management structure.

VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials
PR Newswire - Thu May 23, 10:24AM CDT
VG Energy, an agricultural biotech company, announces today a strategic alliance with DAK Renewable Research to conduct field trials using LipidMax to increase the corn oil yield. VG Energy is a majority owned subsidiary of VG Life Sciences, Inc. (OTC Pink: VGLS).

VG Life Sciences Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial
PR Newswire - Thu Apr 04, 7:03AM CDT
VG Life Sciences, Inc. (OTC Pink: VGLS), a biotechnology company focused on leveraging its innovative platform technologies for the discovery and development of drug therapies for cancer, infectious disease, and inflammation, announced today positive results from stage two of its Pre-IND Phase I Study to test tolerability and toxicity in patients with advanced stage solid tumors. The study, which is ongoing in patients with refractory or relapsed solid tumors, examines the safety and efficacy of hydroxychloroquine (HCQ), developed with VGLS' proprietary metabolic disruption technology (MDT), in combination with sorafenib (marketed as Nexavar®), which was co-developed by Bayer AG and Onyx Pharmaceuticals.

VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
PR Newswire - Fri Mar 22, 8:00AM CDT
VG Life Sciences, Inc. (OTC Pink: VGLS), a biotechnology company focused on leveraging its innovative platform technologies for the discovery and development of drug therapies for cancer, infectious disease, and inflammation, announced today that it has signed a two-year commitment to provide funding toward the operational needs of the company from current investor MedBridge, LLC, a leading provider of development, turnaround, partnership advising and revenue cycle management services for the medical and healthcare industries. During this period, MedBridge will also provide full administrative support for VG Life Sciences, allowing the company to focus on clinical development of its therapeutic pipeline.

VG Life Sciences Subsidiary, VGEnergy, Hires Chief Science Advisor
Business Wire - Thu Feb 28, 7:30AM CST
VG Life Sciences (OTC Pink: VGLS) announces that Martin B. Dickman, Ph.D., has joined its subsidiary VGEnergy, as Chief Science Advisor. In concert with the company's Board of Directors, Dr. Dickman will enhance the scientific rigor of the company's alternative energy core technology platform and expand development of a pipeline of products that enhance the lipid and sugar production in emerging market sectors, such as algal biofuels, and significantly, in more mature and much larger markets, such as corn and sugar cane.

VG Life Sciences Reports Positive Results from First Stage of Ovarian Cancer Clinical Trial Using Sorafenib (Nexavar) Combined with Hydroxychloroquine
Business Wire - Thu Jan 31, 7:30AM CST
--Company Proceeds to Second Set of Patients

VG Life Sciences Expands Ovarian Cancer Trial; Approved to Study Treatment of Breast, Colon, Lung, Liver and Pancreas Cancer
Business Wire - Mon Jan 14, 3:06PM CST
VG Life Sciences (OTC Pink: VGLS), has received approval from the Institutional Review Board of the University of Texas Health Science Center San Antonio to expand the types of cancers being studied in the Company's ongoing physician-initiated Phase 1 clinical trial. The IRB action allows the study to immediately broaden scope to the treatment of all solid tumors, which includes a wide and diverse range of cancer types including breast, colon, lung, liver and pancreas cancer. Effective immediately, principal investigator Dr. Tyler Curiel will begin screening patients with all solid tumors to study the safety of hydroxychloroquine (HCQ) in combination with sorafenib (marketed as Nexevar(TM) by Bayer AG). VG Life Sciences holds the exclusive worldwide license to the body of patents underlying the use of MDT compounds in the treatment of cancers.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elisity’s Texas Water Pilot Puts IonQ’s Deal in View

Updated Category News Views 45

Water-system security is not a place for chest-thumping Elisity’s role in Texas Project Watershed 250 lands on a problem that is painfully concrete: water and wastewater utilities have to keep pumps, treatment systems and plant operations running while trying to close cybersecurity gaps. That is a tougher job than selling another dashboard to a corporate IT department....

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 327

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Arbor Realty Trust Faces Securities Fraud Allegations

Updated Category News Views 108

Securities Lawsuit Against Arbor Realty Trust Looms Well, here we go again. Another day, another securities lawsuit hitting the headlines. This time it's Arbor Realty Trust (NYSE: ABR) getting caught in the crossfire, accused of pulling the wool over investors' eyes. Seems like 'truth in advertising' is just part of the PR playbook for some big shots. Understanding the...

Continue Reading
Sabre Unveils AI Travel Tech: A Bold New Frontier

Updated Category News Views 110

Sabre's Game-Changing AI Travel Integration I'm no stranger to bold moves in the travel industry, but what Sabre's rolling out tomorrow might just be the biggest leap we've seen in a while. They're unleashing what's called the first global travel plug-in within Grok Bot, marking a significant shake-up in the travel tech sphere. Too many tech upgrades in this business...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 17

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 226

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Palm Beach Loan Company Tests Luxury Lending Demand

Updated Category News Views 0

Jewelry in a safe is dead capital until somebody lends against it. That plain fact sits behind Luxury Asset Capital's latest move: the launch of Palm Beach Loan Company, a South Florida brand aimed at wealthy owners of watches, diamonds, art, handbags, gold, collectibles, and other high-value possessions. The company is not asking clients to sell the stuff they spent...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 179

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Greenberg Traurig Cheers Clients' 69th GRAMMY® Nods

Updated Category News Views 124

A Momentous Occasion for Greenberg Traurig's Entertainment Clients Oh, the glamour and glitz of the music world! There's nothing quite like the GRAMMY® Awards to stir up a blend of excitement, ego, and anxiety in the industry. This time around, the lawyers over at Greenberg Traurig are beaming with pride as their clients scoop up nominations for the 69th Annual GRAMMY®...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 268

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting New Dining and Shopping Experiences Coming to Cotino

Updated Category News Views 309

Exciting Developments at Cotino Bay Beach A vibrant new community is set to emerge with the opening of Cotino Bay Beach, Dining and Shops in fall 2026. The first Storyliving by Disney community is gearing up to offer an array of dining and retail experiences, creating a unique destination for residents and visitors alike. Restaurants to Enrich the Community Among the...

Continue Reading
dsm-firmenich Expands Share Repurchase Program for Growth

Updated Category News Views 227

Introduction to the Share Repurchase Program dsm-firmenich, a leader in nutrition, health, and beauty, has embarked on a significant share repurchase program with the aim of enhancing shareholder value and strategically managing its capital. By initiating this buyback, dsm-firmenich demonstrates its commitment to returning value to its investors while still investing in...

Continue Reading
Investigation into Arvinas, Inc. Over Securities Fraud Claims

Updated Category News Views 561

Investigation of Arvinas, Inc. Pomerantz LLP is looking into potential claims on behalf of investors of Arvinas, Inc. (NASDAQ: ARVN). This investigation aims to uncover whether the company and its executives may have engaged in securities fraud or other illegal business practices. Recent Developments Arvinas has recently communicated significant changes to its clinical...

Continue Reading
Gantry Enhances Mortgage Banking with Triad Capital Acquisition

Updated Category News Views 145

Gantry got its hands on Triad Capital Advisors back in 2023, and it was no small move. This merger wasn't just about beefing up their operational muscle; it expanded Gantry's footprint in the Midwest finance scene big time. It’s like they dropped a bomb on their competitors without warning—traders watching closely could feel the shift coming. With this acquisition,...

Continue Reading
Port Athena Debuts with PENETRON Solution in Tartu

Updated Category News Views 32

The Emergence of Port Athena in Tartu Move over, sleepy towns—Tartu's staking its claim with the Port Athena development. What we're looking at is more than just another block of buildings. It's practically a new district, nestled on the banks of the Emajõgi River. Forget the stereotypical old-world charm; we're talking sleek, modern architecture that's ready to become...

Continue Reading